ZNF628
gene geneOn this page
Also known as ZECZfp628
Summary
ZNF628 (zinc finger protein 628, HGNC:28054) is a protein-coding gene on chromosome 19q13.42, encoding Zinc finger protein 628 (Q5EBL2). Transcriptional activator.
Zinc finger proteins (ZNFs), which bind nucleic acids, perform many key functions, the most important of which is regulating transcription. See ZNF91 (MIM 603971) for general information on ZNFs.
Source: NCBI Gene 89887 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_033113
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28054 |
| Approved symbol | ZNF628 |
| Name | zinc finger protein 628 |
| Location | 19q13.42 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZEC, Zfp628 |
| Ensembl gene | ENSG00000197483 |
| Ensembl biotype | protein_coding |
| OMIM | 610671 |
| Entrez | 89887 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000591164, ENST00000598519
RefSeq mRNA: 1 — MANE Select: NM_033113
NM_033113
CCDS: CCDS33116
Canonical transcript exons
ENST00000598519 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001509550 | 55476617 | 55476807 |
| ENSE00003543043 | 55479834 | 55479917 |
| ENSE00003607687 | 55481201 | 55484487 |
Expression profiles
Bgee: expression breadth ubiquitous, 189 present calls, max score 92.18.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.9131 / max 89.2489, expressed in 1748 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177619 | 7.8778 | 1729 |
| 177620 | 1.0352 | 694 |
Top tissues by expression
234 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 92.18 | gold quality |
| left testis | UBERON:0004533 | 82.34 | gold quality |
| right testis | UBERON:0004534 | 82.02 | gold quality |
| gastrocnemius | UBERON:0001388 | 80.96 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.86 | gold quality |
| testis | UBERON:0000473 | 79.85 | gold quality |
| muscle of leg | UBERON:0001383 | 78.54 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 78.17 | gold quality |
| granulocyte | CL:0000094 | 77.48 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.03 | silver quality |
| buccal mucosa cell | CL:0002336 | 76.33 | silver quality |
| kidney epithelium | UBERON:0004819 | 75.94 | gold quality |
| apex of heart | UBERON:0002098 | 75.29 | gold quality |
| cerebellar vermis | UBERON:0004720 | 74.78 | gold quality |
| mucosa of stomach | UBERON:0001199 | 74.43 | gold quality |
| stromal cell of endometrium | CL:0002255 | 74.12 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 74.07 | gold quality |
| skin of abdomen | UBERON:0001416 | 74.05 | gold quality |
| skin of leg | UBERON:0001511 | 74.05 | gold quality |
| lower esophagus | UBERON:0013473 | 74.05 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 73.94 | gold quality |
| pancreatic ductal cell | CL:0002079 | 73.76 | silver quality |
| bone marrow cell | CL:0002092 | 73.76 | gold quality |
| popliteal artery | UBERON:0002250 | 73.67 | gold quality |
| leukocyte | CL:0000738 | 73.64 | gold quality |
| tibial artery | UBERON:0007610 | 73.64 | gold quality |
| monocyte | CL:0000576 | 73.46 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 73.46 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 73.43 | gold quality |
| left uterine tube | UBERON:0001303 | 73.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.65 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
1 targeting ZNF628, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6889-5P | 90.26 | 64.13 | 291 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp628 | ENSMUSG00000074406 |
| rattus_norvegicus | Zfp628 | ENSRNOG00000038622 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 628 — Q5EBL2 (reviewed: Q5EBL2)
All UniProt accessions (2): Q5EBL2, K7EL41
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional activator. Binds DNA on GT-box consensus sequence 5’-TTGGTT-3’. Plays a role in spermiogenesis.
Subunit / interactions. Interacts with TAF4B.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_149104* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (36 total): zinc finger region 16, region of interest 6, compositionally biased region 5, repeat 4, modified residue 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5EBL2-F1 | 58.39 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 199, 589
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 50 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MARTENS_TRETINOIN_RESPONSE_DN, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, SRC_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CREB3L4_TARGET_GENES, NCOA6_TARGET_GENES, NKX2_2_TARGET_GENES, ZNF592_TARGET_GENES, ZNF711_TARGET_GENES, ZNF92_TARGET_GENES, GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN, GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN
GO Biological Process (4): regulation of DNA-templated transcription (GO:0006355), spermatogenesis (GO:0007283), regulation of transcription by RNA polymerase II (GO:0006357), developmental process (GO:0032502)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| transcription by RNA polymerase II | 1 |
| biological_process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
572 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF628 | KIAA0408 | Q6ZU52 | 576 |
| ZNF628 | TCEAL4 | Q96EI5 | 559 |
| ZNF628 | FGD1 | P98174 | 489 |
| ZNF628 | MIS18BP1 | Q6P0N0 | 482 |
| ZNF628 | CAMTA2 | O94983 | 456 |
| ZNF628 | CCDC80 | Q76M96 | 447 |
| ZNF628 | INAFM1 | C9JVW0 | 447 |
| ZNF628 | SAMD4A | Q9UPU9 | 443 |
| ZNF628 | ECSIT | Q9BQ95 | 431 |
| ZNF628 | ZBED6 | P86452 | 424 |
| ZNF628 | SCAMP5 | Q8TAC9 | 415 |
| ZNF628 | MSMB | P08118 | 382 |
| ZNF628 | UBALD1 | Q8TB05 | 377 |
| ZNF628 | RUNDC1 | Q96C34 | 371 |
| ZNF628 | GTF2A1 | P52655 | 361 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EXOC8 | ZNF628 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA6L9 | ZNF628 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF628 | MIEF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF628 | EXOC8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EFEMP1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| SCRIB | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| FBLN2 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| P4HA1 | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
| AFG2B | MMP24OS | psi-mi:“MI:0914”(association) | 0.350 |
| GOLGA6L9 | ZNF628 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF628 | GOLGA6L9 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MIEF2 | ZNF628 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (22): ZNF628 (Affinity Capture-MS), ZNF628 (Affinity Capture-RNA), ZNF628 (Two-hybrid), ZNF628 (Two-hybrid), GOLGA6L9 (Two-hybrid), ZNF628 (Affinity Capture-MS), ZNF628 (Affinity Capture-MS), ZNF628 (Affinity Capture-MS), ZNF628 (Affinity Capture-MS), ZNF628 (Affinity Capture-MS), ZNF628 (Affinity Capture-MS), ZNF628 (Affinity Capture-MS), ZNF628 (Affinity Capture-MS), ZNF628 (Affinity Capture-RNA), ZNF628 (Affinity Capture-MS)
ESM2 similar proteins: A2A5K6, A6QR00, D4A8X0, E9Q6W4, G3V893, O15015, O15156, O95863, P0CJ78, P10074, Q02085, Q13105, Q29RK0, Q3U3I9, Q4R8S8, Q504L7, Q5EBL2, Q5F293, Q5R4P8, Q5RJR4, Q60821, Q66K89, Q6DD87, Q6GL52, Q6NV66, Q6PGE4, Q6YND2, Q6ZN55, Q80VM4, Q8BI66, Q8BI69, Q8BIF9, Q8BY46, Q8CCE9, Q8CJ78, Q8JZL0, Q8N1W2, Q8NCA9, Q8TF50, Q8WUU4
Diamond homologs: O15090, O43167, P17041, P18732, P18744, P18747, Q5EBL2, Q62255, Q80X44, Q8CJ78, Q8K083, Q8TBZ5, Q96BV0, Q9BXA9, Q9ER74, Q9NSC2, Q9UDV7, O15391, P08045, P18712, P18731, P25490, P38621, Q00899, Q19A41, Q3TTC2, Q86T29, Q86UQ0, Q8BI66, Q8BIQ3, Q8BX22, Q8ST83, Q8TF50, Q96LX8, Q99PV8, Q9H165, Q9H4T2, Q9QYE3, Q9UJQ4, Q9VHJ6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 40 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
352 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:55477198:G:T | donor_gain | 0.9700 |
| 19:55476803:CGCAG:C | donor_loss | 0.9600 |
| 19:55476804:GCAGG:G | donor_loss | 0.9600 |
| 19:55476805:CAG:C | donor_loss | 0.9600 |
| 19:55476806:AG:A | donor_loss | 0.9600 |
| 19:55476807:GGTG:G | donor_loss | 0.9600 |
| 19:55476808:G:A | donor_loss | 0.9600 |
| 19:55476809:T:G | donor_loss | 0.9600 |
| 19:55481195:CCCCA:C | acceptor_loss | 0.9500 |
| 19:55481196:CCCA:C | acceptor_loss | 0.9500 |
| 19:55481197:CCA:C | acceptor_loss | 0.9500 |
| 19:55481198:CAGG:C | acceptor_loss | 0.9500 |
| 19:55481199:A:C | acceptor_loss | 0.9500 |
| 19:55481200:G:T | acceptor_loss | 0.9500 |
| 19:55481200:GGT:G | acceptor_gain | 0.9500 |
| 19:55477243:G:T | donor_gain | 0.9200 |
| 19:55481199:A:AG | acceptor_gain | 0.9200 |
| 19:55481200:G:GG | acceptor_gain | 0.9200 |
| 19:55477199:G:T | donor_gain | 0.9000 |
| 19:55476679:G:GT | donor_gain | 0.8900 |
| 19:55477243:G:GT | donor_gain | 0.8700 |
| 19:55481188:ATCCC:A | acceptor_loss | 0.8600 |
| 19:55481189:TCCCT:T | acceptor_loss | 0.8600 |
| 19:55481190:CCCTC:C | acceptor_loss | 0.8600 |
| 19:55481191:CCTCC:C | acceptor_loss | 0.8600 |
| 19:55481192:CTCCC:C | acceptor_loss | 0.8600 |
| 19:55476648:T:G | donor_gain | 0.8500 |
| 19:55481187:AATCC:A | acceptor_loss | 0.8500 |
| 19:55481193:TCCCC:T | acceptor_loss | 0.8500 |
| 19:55481194:CCCCC:C | acceptor_loss | 0.8500 |
AlphaMissense
6741 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:55481326:T:C | F45L | 1.000 |
| 19:55481328:C:A | F45L | 1.000 |
| 19:55481328:C:G | F45L | 1.000 |
| 19:55481353:C:A | H54N | 1.000 |
| 19:55481353:C:G | H54D | 1.000 |
| 19:55481389:T:C | C66R | 1.000 |
| 19:55481398:T:C | C69R | 1.000 |
| 19:55481410:T:C | F73L | 1.000 |
| 19:55481411:T:C | F73S | 1.000 |
| 19:55481412:C:A | F73L | 1.000 |
| 19:55481412:C:G | F73L | 1.000 |
| 19:55481437:C:G | H82D | 1.000 |
| 19:55481494:T:C | F101L | 1.000 |
| 19:55481495:T:C | F101S | 1.000 |
| 19:55481496:C:A | F101L | 1.000 |
| 19:55481496:C:G | F101L | 1.000 |
| 19:55481521:C:G | H110D | 1.000 |
| 19:55481557:T:C | C122R | 1.000 |
| 19:55481578:T:C | F129L | 1.000 |
| 19:55481579:T:C | F129S | 1.000 |
| 19:55481580:C:A | F129L | 1.000 |
| 19:55481580:C:G | F129L | 1.000 |
| 19:55481605:C:G | H138D | 1.000 |
| 19:55481641:T:C | C150R | 1.000 |
| 19:55481650:T:C | C153R | 1.000 |
| 19:55481662:T:C | F157L | 1.000 |
| 19:55481664:C:A | F157L | 1.000 |
| 19:55481664:C:G | F157L | 1.000 |
| 19:55481746:T:C | F185L | 1.000 |
| 19:55481747:T:C | F185S | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000040544 (19:55482939 G>A), RS1000057773 (19:55483437 C>T), RS1000306157 (19:55484954 C>G,T), RS1000432426 (19:55480162 G>T), RS1000934044 (19:55477017 C>T), RS1001275739 (19:55483753 G>A), RS1001284360 (19:55476721 C>A,T), RS1001890103 (19:55477494 G>A), RS1002272881 (19:55481119 C>G,T), RS1002282237 (19:55476600 C>T), RS1002629067 (19:55478338 G>A,C), RS1002774447 (19:55477353 G>T), RS1002935256 (19:55474900 A>C,G), RS1002946866 (19:55478568 C>G,T), RS1003293343 (19:55474696 A>C)
Disease associations
OMIM: gene MIM:610671 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008362_35 | Birth weight | 2.000000e-09 |
| GCST012227_1355 | Hip circumference adjusted for BMI | 2.000000e-10 |
| GCST90000025_575 | Appendicular lean mass | 9.000000e-32 |
| GCST90000026_17 | Appendicular lean mass | 3.000000e-22 |
| GCST90000027_3 | Appendicular lean mass | 2.000000e-13 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004344 | birth weight |
| EFO:0008039 | BMI-adjusted hip circumference |
| EFO:0004980 | appendicular lean mass |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
32 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases methylation, affects cotreatment, decreases expression | 3 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Air Pollutants | affects expression, increases abundance, decreases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases expression | 2 |
| fluorene-9-bisphenol | decreases expression | 1 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| ochratoxin A | decreases expression | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| licochalcone B | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic Trioxide | decreases expression | 1 |
| Hexachlorocyclohexane | decreases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Diazinon | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Propanil | decreases expression | 1 |
| Silicon Dioxide | decreases methylation | 1 |
| Smoke | increases expression | 1 |
| Thiram | increases expression | 1 |
| Urethane | affects expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Sirolimus | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.